Literature DB >> 7724089

Risk factors for preeclampsia in twin pregnancies: a population-based cohort study.

D V Coonrod1, D E Hickok, K Zhu, T R Easterling, J R Daling.   

Abstract

OBJECTIVE: To evaluate in twin pregnancies the characteristics parity, race, smoking, and age, known to be risk factors for preeclampsia in non-twin pregnancies.
METHODS: All twin pregnancies (3407) and approximately twice as many singletons (8287) were assembled using Washington state birth certificates from the period 1984-1988.
RESULTS: In singleton pregnancies, preeclampsia was more common in women who were younger, black, poor, nulliparous, and nonsmokers. In twin pregnancies, similar associations were found, but were only statistically significant for age, race, and parity. There were no significant differences in the risk factors between twin and singleton women. Logistic regression showed that twin pregnancy carries a relative risk (RR) of 3.5 (95% confidence interval [CI] 3.0-4.2), nulliparity an RR of 4.0 (95% CI 3.3-4.8), and black race an RR of 1.8 (95% CI 1.2-2.6) for preeclampsia. In each case, this risk is independent of the other risk factors.
CONCLUSION: Twin pregnancy carries nearly a fourfold increased risk of preeclampsia, independent of race and parity, and the risk of a nulliparous twin pregnancy is 14 times that of a parous singleton pregnancy. Risk factors in a singleton pregnancy act similarly in a twin pregnancy. Thus, any pathophysiologic model for preeclampsia needs to account for the risk twin pregnancy poses as well as other risk factors, such as parity and race.

Entities:  

Mesh:

Year:  1995        PMID: 7724089     DOI: 10.1016/0029-7844(95)00049-w

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  22 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  Effect of changes in renal circulation on serum uric acid levels in women with twin pregnancy.

Authors:  Miwa Igarashi; Hidehiko Miyake; Shunji Suzuki
Journal:  Clin Exp Nephrol       Date:  2010-06-17       Impact factor: 2.801

Review 3.  Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies.

Authors:  Kirsten Duckitt; Deborah Harrington
Journal:  BMJ       Date:  2005-03-02

4.  Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies.

Authors:  Kelly K Ferguson; John D Meeker; Thomas F McElrath; Bhramar Mukherjee; David E Cantonwine
Journal:  Am J Obstet Gynecol       Date:  2016-12-30       Impact factor: 8.661

5.  Maternal pre-gravid body mass index and obstetric outcomes in twin gestations.

Authors:  S Al-Obaidly; J Parrish; K E Murphy; C Maxwell
Journal:  J Perinatol       Date:  2014-03-06       Impact factor: 2.521

6.  Psychoneuroimmunology in pregnancy: immune pathways linking stress with maternal health, adverse birth outcomes, and fetal development.

Authors:  Lisa M Christian
Journal:  Neurosci Biobehav Rev       Date:  2011-07-19       Impact factor: 8.989

7.  Effect of smoking on circulating angiogenic factors in high risk pregnancies.

Authors:  Arun Jeyabalan; Robert W Powers; Rebecca G Clifton; Peter Van Dorsten; John C Hauth; Mark A Klebanoff; Marshall D Lindheimer; Baha Sibai; Mark Landon; Menachem Miodovnik
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

8.  Pre-eclampsia (PE) and Chorionicity in Women with Twin Gestations.

Authors:  Anupama Singh; Arati Singh; Tarakeswari Surapaneni; Praveen Kumar Nirmalan
Journal:  J Clin Diagn Res       Date:  2013-12-03

9.  Determinants of Pre-eclampsia: A Case-control Study in a District Hospital in South India.

Authors:  Kumar S Ganesh; B Unnikrishnan; K Nagaraj; S Jayaram
Journal:  Indian J Community Med       Date:  2010-10

10.  PPAR Action in Human Placental Development and Pregnancy and Its Complications.

Authors:  Fritz Wieser; Leslie Waite; Christophe Depoix; Robert N Taylor
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.